Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Biostatistics (Oxford, England)|March 20, 2008
Optimal screening for promising genes in 2-stage designsB Moerkerke, E GoetghebeurBiometrics|May 24, 2003
A causal proportional hazards estimator for the effect of treatment actually received in a randomized trial with all-or-nothing complianceT Loeys, E GoetghebeurStatistics in Medicine|October 30, 2004
Sense and sensitivity when correcting for observed exposures in randomized clinical trialsS Vansteelandt, E GoetghebeurJournal of Computational Biology : a Journal of Computational Molecular Cell Biology|December 7, 2006
Selecting "significant" differentially expressed genes from the combined perspective of the null and the alternativeB Moerkerke, E GoetghebeurStatistical Methods in Medical Research|January 15, 2000
The impact of compliance in pharmacokinetic studiesB Vrijens, E GoetghebeurControlled Clinical Trials|June 1, 1997
Comparing compliance patterns between randomized treatmentsB Vrijens, E GoetghebeurBiometrics|December 29, 2000
Semiparametric regression analysis of interval-censored dataE Goetghebeur, L RyanStatistics in Medicine|July 12, 2002
Baseline information in structural failure time estimators for the effect of observed treatment complianceT Loeys, E GoetghebeurControlled Clinical Trials|December 10, 1999
Practical properties of some structural mean analyses of the effect of compliance in randomized trialsK Fischer-Lapp, E GoetghebeurStatistics in Medicine|January 10, 2002
Accounting for correlation and compliance in cluster randomized trialsT Loeys, S Vansteelandt, E GoetghebeurPageof 3